Cyclin E

International Journal of Biochemistry and Cell Biology

Volumn 36, Issue 8, 2004, Pages 1424-1439

  Möröy, Tarik ^a   Geisen, Christoph ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Cancer; Cdk; Cell cycle; Cyclin E; G1 progression

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN E; ONCOPROTEIN; PROTEASOME; TRANSCRIPTION FACTOR E2F;

CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CENTROSOME; COMPLEX FORMATION; DEVELOPMENT; DNA REPLICATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; EUKARYOTE; EUKARYOTIC CELL; GENETIC STABILITY; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; KNOCKOUT MOUSE; LEUKEMIA; LYMPHOMA; MITOSIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; STRUCTURE ANALYSIS; TRANSGENIC MOUSE;

ANIMALS; CDC2-CDC28 KINASES; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; HUMANS; INTERPHASE; NEOPLASMS; UBIQUITIN;

EUKARYOTA; MUS MUSCULUS;

EID: 2442631698     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2003.12.005     Document Type: Review

References (170)

1. Adams P.D., Sellers W.R., Sharma S.K., Wu A.D., Nalin C.M., Kaelin W.G. Jr. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Molecular and Cellular Biology. 16:1996;6623-6633
2. Akama Y., Yasui W., Yokozaki H., Kuniyasu H., Kitahara K., Ishikawa T., et al. Frequent amplification of the cyclin E gene in human gastric carcinomas. Japan Journal of Cancer Research. 86:1995;617-621
3. Akama Y., Yasui W., Kuniyasu H., Yokozaki H., Akagi M., Tahara H., et al. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines. Japan Journal of Cancer Research. 87:1996;824-830
4. Allan A.L., Albanese C., Pestell R.G., LaMarre J. Activating transcription factor 3 induces DNA synthesis and expression of cyclin D1 in hepatocytes. Journal of Biological Chemistry. 276:2001;27272-27280
5. Arata Y., Fujita M., Ohtani K., Kijima S., Kato J.Y. Cdk2-dependent and -independent pathways in E2F-mediated S phase induction. Journal of Biological Chemistry. 275:2000;6337-6345
6. Ashizawa S., Nishizawa H., Yamada M., Higashi H., Kondo T., Ozawa H., et al. Collective inhibition of pRB family proteins by phosphorylation in cells with pl6INK4a loss or cyclin E overexpression. Journal of Biological Chemistry. 4:2001;4
7. Berthet C., Aleem E., Coppola V., Tessarollo L., Kaldis P. Cdk2 knockout mice are viable. Current Biology. 13:2003;1775-1785
8. Botner D.M., Rosenberg M.P. Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis. Cell Growth Difference. 6:1995;1579-1589
9. Botner D.M., Rosenberg M.P. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Molecular and Cellular Biology. 17:1997;453-459
10. Botz J., Zerfass-Thome K., Spitkovsky D., Delius H., Vogt B., Eilers M., et al. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Molecular and Cellular Biology. 16:1996;3401-3409
11. Brown N.R., Noble M.E., Endicott J.A., Garman E.F., Wakatsuki S., Mitchell E., et al. The crystal structure of cyclin A. Structure. 3:1995;1235-1247
12. Carroll P.E., Okuda M., Horn H.F., Biddinger P., Stambrook P.J., Gleich L.L., et al. Centrosome hyperamplification in human cancer: Chromosome instability induced by p53 mutation and/or Mdm2 overexpression. Oncogene. 18:1999;1935-1944
13. Castano E., Kleyner Y., Dynlacht B.D. Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor. Molecular and Cellular Biology. 18:1998;5380-5391
14. Catzavelos C., Bhattacharya N., Ung Y.C., Wilson J.A., Roncari L., Sandhu C., et al. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer. Nature of Medicine. 3:1997;227-230. [see comments]
15. Chang Z.F., Huang D.Y., Lai T.C. Different regulation of the human thymidine kinase promoter in normal human diploid IMR-90 fibroblasts and HeLa cells. Journal of Biological Chemistry. 270:1995;27374-27379
16. Chen J., Saha P., Kornbluth S., Dynlacht B.D., Dutta A. Cyclin-binding motifs are essential for the function of p2lCIP1. Molecular and Cellular Biology. 16:1996;4673-4682
17. Chen Z., Indjeian V.B., McManus M., Wang L., Dynlacht B.D. CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells. Developmental Cells. 3:2002;339-350
18. Cheng A., Kaldis P., Solomon M.J. Dephosphorylation of human cyclin-dependent kinases by protein phosphatase type 2C alpha and beta 2 isoforms. Journal of Biological Chemistry. 275:2000;34744-34749
19. Clurman B.E., Sheaff R.J., Thress K., Groudine M., Roberts J.M. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Development. 10:1996;1979-1990
20. Coverley D., Laman H., Laskey R.A. Distinct roles for cyclins E and A during DNA replication complex assembly and activation. Nature of Cell Biology. 4:2002;523-528
21. Cross F.R., Yuste-Rojas M., Gray S., Jacobson M.D. Specialization and targeting of B-type cyclins. Molecular Cells. 4:1999;11-19
22. Deed R.W., Hara E., Atherton G.T., Peters G., Norton J.D. Regulation of Id3 cell cycle function by Cdk-2-dependent phosphorylation. Molecular and Cellular Biology. 17:1997;6815-6821
23. DeGregori J., Kowalik T., Nevins J.R. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Molecular and Cellular Biology. 15:1995;4215-4224
24. Demetrick D.J., Matsumoto S., Hannon G.J., Okamoto K., Xiong Y., Zhang H., et al. Chromosomal mapping of the genes for the human cell cycle proteins cyclin C (CCNC), cyclin E (CCNE), p21 (CDKN1) and KAP (CDKN3). Cytogenetics and Cell Genetics. 69:1995;190-192
25. Diehl J.A., Sherr C.J. A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kianase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Molecular and Cellular Biology. 17:1997;7362-7374
26. Dong Y., Sui L., Tai Y., Sugimoto K., Hirao T., Tokuda M. Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas. Clinical Cancer Research. 6:2000;4253-4258
27. Donnellan R., Chetty R. Cyclin D1 and human neoplasia. Molecular Pathology. 51:1998;1-7
28. Donnellan R., Chetty R. Cyclin E in human cancers. FASEB Journal. 13:1999;773-780
29. Donzelli M., Draetta G.F. Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Reports. 4:2003;671-677
30. Dulic V., Lees E., Reed S.I. Association of human cyclin E with a periodic G1-S phase protein kinase. Science. 257:1992;1958-1961
31. Duronio R.J., O'Farrell P.H. Developmental control of the G1 to S transfition in Drosophila: Cyclin Eis a limiting downstream target of E2F. Genes Development. 9:1995;1456-1468
32. Dutta A., Chandra R., Leiter L.M., Lester S. Cyclins as markers of tumor proliferation: Immunocytochemical studies in breast cancer. Proceedings of the National Academic Sciences of the United States of America. 92:1995;5386-5390
33. Ekholm S.V., Zickert P., Reed S.I., Zetterberg A. Accumulation of cyclin E is not a prerequisite for passage through the restriction point. Molecular and Cellular Biology. 21:2001;3256-3265
34. Erlanson M., Landberg G. Prognostic implications of p27 and cyclin E protein contents in malignant lymphomas. Leukemya Lymphoma. 40:2001;461-470
35. Erlanson M., Portin C., Linderholm B., Lindh J., Roos G., Landberg G. Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications. Blood. 92:1998;770-777
36. Evans T., Rosenthal E.T., Youngblom J., Distel D., Hunt T. Cyclin: A protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell. 33:1983;389-396
37. Ezhevsky S.A., Ho A., Becker-Hapak M., Davis P.K., Dowdy S.F. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Molecular and Cellular Biology. 21:2001;47734784
38. Fredersdort S., Burns J., Milne A.M., Packham G., Fallis L., Gillett C.E., et al. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proceedings of the National Academic Sciences of the United States of America. 94:1997;6380-6385
39. Fukuse T., Hirata T., Naiki H., Hitomi S., Wada H. Prognostic significance of cyclin E overexpression in resected non-small cell lung cancer. Cancer Research. 60:2000;242-244
40. Furstenthal L., Kaiser B.K., Swanson C., Jackson P.K. Cyclin E uses Cdc6 as a chromatin-associated receptor required for DNA replication. Journal of Biological Chemistry. 152:2001;1267-1278
41. Geisen C., Möröy T. The oncogenic activity of cyclin E is not confirmed to Cdk2 activation alone but relies on several other, distinct functions of the protein. J. Biol. Chem. 277:2002;39909-39918
42. Geisen C., Karsunky H., Yücel R., Möröy T. Loss of p27(Kip1) cooperates with cyclin E in T-cell lymphomagenesis. Oncogene. 22:2003;1724-1729
43. Geng Y., Eaton E.N., Picon M., Roberts J.M., Lundberg A.S., Gifford A., et al. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene. 12:1996;1173-1180
44. Geng Y., Whoriskey W., Park M.Y., Bronson R.T., Medema R.H., Li T., et al. Rescue of cyclin D1 deficiency by knockin cyclin E. Cell. 97:1999;767-777
45. Geng Y., Yu Q., Whoriskey W., Dick F., Tsai K.Y., Ford H.L., et al. Expression of cyclins E1 and E2 during mouse development and in neoplasia. Proceedings of the National Academic Sciences of the United States of America. 98:2001;13138-13143
46. Geng Y., Yu Q., Sicinska E., Das M., Schneider J.E., Bhattacharya S., et al. Cyclin E ablation in the mouse. Cell. 114:2003;431-443
47. Gladden A.B., Diehl J.A. Cell cycle progression without cyclin E/CDK2: Breaking down the walls of dogma. Cancer Cell. 4:2003;160-162
48. Grim J.E., Clurman B.E. Cycling without CDK2? Trends in Cell Biology. 13:2003;396-399
49. Gudas J.M., Payton M., Thukral S., Chen E., Bass M., Robinson M.O., et al. Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers. Molecular and Cellular Biology. 19:1999;612-622
50. Haas K., Johannes C., Geisen C., Schmidt T., Karsunky H., Blass-Kampmann S., et al. Malignant transformation by cyclin E and Ha-Ras correlates with lower sensitivity towards induction of cell death but requires functional Myc and CDK4. Oncogene. 15:1997;2615-2623
51. Hall M., Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Advances in Cancer Research. 68:1996;67-108
52. Hall C., Nelson D.M., Ye X., Baker K., DeCaprio J.A., Seeholzer S., et al. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression. Molecular and Cellular Biology. 21:2001;1854-1865
53. Hannon G.J., Demetrick D., Beach D. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Development. 7:1993;2378-2391
54. Hara E., Hall M., Peters G. Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors. Embo J. 16:1997;332-342
55. Harbour J.W., Luo R.X., Dei Santi A., Postigo A.A., Dean D.C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell. 98:1999;859-869
56. Harwell R.M., Porter D.C., Danes C., Keyomarsi K. Processing of cyclin E differs between normal and tumor breast cells. Cancer Research. 60:2000;481-489
57. Herber B., Truss M., Beato M., Muller R. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene. 9:1994;1295-1304
58. Hinchcliffe E.H., Li C., Thompson E.A., Maller J.L., Sluder G. Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science. 283:1999;851-854. [see comments]
59. Hinchcliffe E.H., Sluder G. Centrosome duplication: Three kinases come up a winner. Current Biology. 11:2001;R698-701
60. Hinchcliffe E.H., Sluder G. Two for two: Cdk2 and its role in centrosome doubling. Oncogene. 21:2002;6154-6160
61. Iavarone A., Massague J. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15. Nature. 387:1997;417-422
62. Iida H., Towatari M., Tanimoto M., Morishita Y., Kodera Y., Saito H. Overexpression of cyclin E in acute myelogenous leukemia. Blood. 90:1997;3707-3713
63. Jackman M., Kubota Y., den Elzen N., Hagting A., Pines J. Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm. Molecular Biology of Cells. 13:2002;1030-1045
64. Kaldis P. The cdk-activating kinase (CAK): From yeast to mammals. Cells and Molecular Life Science. 55:1999;284-296
65. Karsunky H., Geisen C., Schmidt T., Haas K., Zevnik B., Gau E., et al. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: Evidence for cooperation between cyclin E and Ras but not Myc. Oncogene. 18:1999;7816-7824
66. Keating J.T., Cviko A., Riethdorf S., Riethdorf L., Quade B.J., Sun D., et al. Ki-67, cyclin F, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. American Journal of Surgery and Pathology. 25:2001;884-891
67. Kelly B.L., Wolfe K.G., Roberts J.M. Identification of a substrate-targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein. Proceedings of the National Academic Sciences of the United States of America. 95:1998;2535-2540
68. Keyomarsi K., Conte D. Jr., Toyofuku W., Fox M.P. Deregulation of cyclin E in breast cancer. Oncogene. 11:1995;941-950
69. Keyomarsi K., Tucker S.L., Buchholz T.A., Callister M., Ding Y., Hortobagyi G.N., et al. Cyclin E and survival in patients with breast cancer. New England Journal of Medicine. 347:2002;1566-1575
70. Koepp D.M., Schaefer L.K., He X., Keyomarsi K., Chu C., Harper J.W., et al. Phopsphorylation dependent ubiquitination of cyclin e by the SCFFbw7 ubiquitin ligase. Science. 294:2001;173-177
71. Koff A., Giordano A., Desai D., Yamashita K., Harper J.W., Elledge S., et al. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science. 257:1992;1689-1694
72. Koff A., Cross F., Fisher A., Schumacher J., Leguellec K., Philippe M., et al. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell. 66:1991;1217-1228
73. Krude T., Jackman M., Pines J., Laskey R.A. Cyclin/Cdk-dependent initiation of DNA replication in a human cell-free system. Cell. 88:1997;109-119
74. LaBaer J., Garrett M.D., Stevenson L.F., Slingerland J.M., Sandhu C., Chou H.S., et al. New functional activities for the p21 family of CDK inhibitors. Genes Development. 11:1997;847-862
75. Lacey K.R., Jackson P.K., Stearns T. Cyclin-dependent kinase control of centrosome duplication. Proceedings of the National Academic Sciences of the United States of America. 96:1999;2817-2822
76. Lauper N., Beck A.R., Cariou S., Richman L., Hofinann K., Reith W., et al. Cyclin E2: A novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle. Oncogene. 17:1998;2637-2643
77. Le Cam L., Polanowska J., Fabbrizio E., Olivier M., Philips A., Ng Eaton E., et al. Timing of cydin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex. EMBO Journal. 18:1999;1878-1890
78. Lew D.J., Korubluth S. Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control. Current Opinion of Cell Biology. 8:1996;795-804
79. Lew D.J., Dulic V., Reed S.I. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell. 66:1991;1197-1206
80. Li S.F., Shiozawa T., Nakayama K., Nikaido T., Fujii S. Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma. Cancer. 77:1996;321-329
81. Lingle W.L., Lutz W.H., Ingle J.N., Maihle N.J., Salisbury J.L. Centrosome hypertrophy in human breast tumors: Implications for genomic stability and cell polarity. Proceedings of the National Academic Sciences of the United States of America. 95:1998;2950-2955
82. Loden M., Stighall M., Nielsen N.H., Roos G., Emdin S.O., Ostlund H., et al. The cyclin D1 high and cyclin B high subgroups of breast cancer: Separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node. Oncogene. 21:2002;4680-4690
83. Loyer P., Cariou S., Glaise D., Bilodeau M., Baffet G., Guguen-Guillouzo C. Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late G1. Journal of Biological Chemistry. 271:1996;11484-11492
84. Lundberg A.S., Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Molecular and Cellular Biology. 18:1998;753-761
85. Ma T., Van Tine B.A., Wei Y., Garrett M.D., Nelson D., Adams P.D., et al. Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription. Genes Development. 14:2000;2298-2313
86. Mateyak M.K., Obaya A.J., Sedivy J.M. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Molecular and Cellular Biology. 19:1999;4672-4683
87. Matsumoto Y., Hayashi K., Nishida E. Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Current Biology. 9:1999;429-432
88. Matsushime H., Roussel M.F., Ashmun R.A., Sherr C.J. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell. 65:1991;701-713
89. Mazumder S., Gong B., Chen Q., Drazba J.A., Buchsbaum J.C., Almasan A. Proteolytic cleavage of cyclin E leads to inactivation of associated kinase activity and amplification of apoptosis in hematopoietic cells. Molecular and Cellular Biology. 22:2002;2398-2409
90. Moberg K.H., Bell D.W., Wahrer D.C., Haber D.A., Hariharan I.K. Archipelago regulates cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature. 413:2001;311-316
91. Molendini L., Benassi M.S., Magagnoli G., Merli M., Sollazzo M.R., Ragazzini P., et al. Prognostic significance of cyclin expression in human osteosarcoma. International Journal of Oncology. 12:1998;1007-1011
92. Moore J.D., Yang J., Truant R., Kournbluth S. Nuclear import of Cdk/cyclin complexes: Identification of distinct mechanisms for import of Cdk1:2/cyclin E and Cdc2/cyclin B1. Journal of Biological Chemistry. 144:1999;213-224
93. Moore J.D., Kornbluth S., Hunt T. Identification of the nuclear localization signal in Xenopus cyclin e and analysis of its role in replication and mitosis. Molecular Biology of Cells. 13:2002;4388-4400
94. Morris L., Allen K.E., La Thangue N.B. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators. Nature of Cell Biology. 2:2000;232-239
95. Mueller P.R., Coleman T.R., Dunphy W.G. Cell cycle regulation of a Xenopus Wee1-like kinase. Molecular and Cellular Biology. 6:1995;119-134
96. Mueller P.R., Coleman T.R., Kumagai A., Dunphy W.G. Myt1: A membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science. 270:1995;86-90
97. Müller-Tidow C., Metzger R., Kugler K., Diederichs S., Idos G., Thomas M., et al. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Research. 61:2001;647-653
98. Mumberg D., Wick M., Bürger C., Haas K., Funk M., Müller R. Cyclin ET, a new splice variant of human cyclin E with a unique expression pattern during cell cycle progression and differentiation. Nucleic Acids Research. 25:1997;2098-2105
99. Mussman J.G., Horn H.F., Carroll P.E., Okuda M., Tarapore P., Donehower L.A., et al. Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression. Oncogene. 19:2000;1635-1646
100. Nagahara H., Ezhevsky S.A., Vocero-Akbani A.M., Kaldis P., Solomon M.J., Dowdy S.F. Transforming growth factor beta targeted inactivation of cyclin E: Cyclin dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity. Proceedings of the National Academic Sciences of the United States of America. 96:1999;14961-14966
101. Nakamura M., Katano M., Fujimoto K., Morisaki T. A new prognostic strategy for gastric carcinoma: mRNA expression of tumor growth-related factors in endoscopic biopsy specimens. Annals of Surgery. 226:1997;35-42
102. Nakayama K., Nagahama H., Minamishima Y.A., Matsumoto M., Nakamichi I., Kitagawa K., et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kipl), polyploidy and centrosome overduplication. EMBO J. 19:2000;2069-2081
103. Nielsen N.H., Arnerlov C., Emdin S.O., Landberg G. Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. British Journal of Cancer. 74:1996;874-880
104. Nielsen N.H., Emdin S.O., Cajander J., Landberg G. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene. 14:1997;295-304
105. Noya F., Chien W.M., Broker T.R., Chow L.T. p2lcip1 Degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human papillomavirus E7. Journal of Virology. 75:2001;6121-6134
106. Ohtsubo M., Roberts J.M. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science. 259:1993;1908-1912
107. Okuda M. The role of nucleophosmin in centrosome duplication. Oncogene. 21:2002;6170-6174
108. Okuda M., Horn H.F., Tarapore P., Tokuyama Y., Smulian A.G., Chan P.K., et al. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell. 103:2000;127-140
109. Ohtani K., Degregori J., Nevins J.R. Regulation of the cyclin E gene by transcription factor E2F1. Proceedings of the National Academic Sciences of the United States of America. 92:1995;12146-12150
110. Ohtsubo M., Theodoras A.M., Schumacher J., Roberts J.M., Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Molecular and Cellular Biology. 15:1995;2612-2624
111. Ortega S., Prieto I., Odajima J., Martin A., Dubus P., Sotillo R., et al. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nature of Genetics. 35:2003;25-31
112. Pagano M., Tam S.W., Theodoras A.M., Beer-Romero P., Del Sal G., Chau V., et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 269:1995;682-685. [see comments]
113. Parisi T., Beck A.R., Rougier N., McNeil T., Lucian L., Werb Z., et al. Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells. EMBO Journal. 22:2003;4794-4803
114. Parker L.L., Sylvestre P.J., Byrnes M.J. Jr., Liu F., Piwnica-Worms H. Identification of a 95-kDa WEE1-like tyrosine kinase in HeLa cells. Proceedings of the National Academic Sciences of the United States of America. 92:1995;9638-9642
115. Pihan G.A., Purohit A., Wallace J., Knecht H., Woda B., Quesenberry P., et al. Centrosome defects and genetic instability in malignant tumors. Cancer Research. 58:1998;3974-3985
116. Poon R.Y., Hunter T. Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin. Science. 270:1995;90-93
117. Porter D.C., Keyomarsi K. Novel splice variants of cyclin E with altered substrate specificity. Nucleic Acids Research. 28:2000;E101
118. Porter P.L., Malone K.E., Heagerty P.J., Alexander G.M., Gatti L.A., Firpo E.J., et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients [see comments]. Nature of Medicine. 3:1997;222-225
119. Quade B.J., Park J.J., Crum C.P., Sun D., Dutta A. In vivo cyclin E expression as a marker for early cervical neoplasia. Models of Pathology. 11:1998;1238-1246
120. Ray-Gallet D., Quivy J.P., Scamps C., Martini E.M., Lipinski M., Almouzni G. HIRA is critical for a nucleosome assembly pathway independent of DNA synthesis. Molecular Cells. 9:2002;1091-1100
121. Rechsteiner M., Rogers S.W. PEST sequences and regulation by proteolysis. Trends in Biochemical Science. 21:1996;267-271
122. Resnitzky D., Reed S.I. Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Molecular and Cellular Biology. 15:1995;3463-3469
123. Roberts J.M., Sherr C.J. Bared essentials of CDK2 and cyclin E. Nature of Genetics. 35:2003;9-10
124. Rogers S., Wells R., Rechsteiner M. Amino acid sequences common to rapidly degraded proteins: The PEST hypothesis. Science. 234:1986;364-368
125. Roussel M.F. Key effectors of signal transduction and G1 progression. Advances in Cancer Research. 74:1998;1-24
126. Sakaguchi T., Watanabe A., Sawada H., Yamada Y., Yamashita J., Matsuda M., et al. Prognostic value of cyclin E and p53 expression in gastric carcinoma. Cancer. 82:1998;1238-1243
127. Sauer K., Knoblich J.A., Richardson H., Lehner C.F. Distinct modes of cyclin E/cdc2c kinase regulation and S-phase control in mitotic and endoreduplication cycles of Drosophila embryogenesis. Genes Development. 9:1995;1327-1339
128. Schulman B.A., Lindstrom D.L., Harlow E. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proceedings of the National Academic Sciences of the United States of America. 95:1998;10453-10458
129. Scott K.A., Walker R.A. Lack of cyclin B immunoreactivity in non-malignant breast and association with proliferation in breast cancer. British Journal of Cancer. 76:1997;1288-1292
130. Seghezzi W., Chua K., Shanahan F., Gozani O., Reed R., Lees E. Cyclin E associates with components of the pre-mRNA splicing machinery in mammalian cells. Molecular and Cellular Biology. 18:1998;4526-4536
131. Sewing A., Rönicke V., Bürger C., Funk M., Müller R. Alternative splicing of human cyclin E. Journal of Cell Science. 107:1994;581-588
132. Shanahan F., Seghezzi W., Parry D., Mahony D., Lees E. Cyclin E associates with BAF/155 and BRG1, components of the mammalian SWI-SNF complex, and alters the ability of BRG1 to induce growth arrest. Molecular and Cellular Biology. 19:1999;1460-1469
133. Sheaff R.J., Groudine M., Gordon M., Roberts J.M., Clurman B.E. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Development. 11:1997;1464-1478
134. Sherr C.J. Mammalian G1 cyclins. Cell. 73:1993;1059-1065
135. Singer J.D., Gurian-West M., Clurman B., Roberts J.M. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Development. 13:1999;2375-2387
136. Smith E., Frenkel B., MacLachlan T.K., Giordano A., Stein J.L., Lian J.B., et al. Post-proliferative cyclin E-associated kinase activity in differentiated osteoblasts: Inhibition by proliferating osteoblasts and osteosarcoma cells. Journal of Cell Biochemistry. 66:1997;141-152
137. Sofer-Levi Y., Resnitzky D. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene. 13:1996;2431-2437
138. Spruck C.H., Won K.A., Reed S.I. Deregulated cyclin E induces chromosome instability. Nature. 401:1999;297-300
139. Spruck C.H., Strohmaier H., Sangfelt O., Muller H.M., Hubalek M., Muller-Holzner E., et al. hCDC4 gene mutations in endometrial cancer. Cancer Research. 62:2002;4535-4539
140. Strohmaier H., Spruck C.H., Kaiser P., Won K.A., Sangfelt O., Reed S.I. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature. 413:2001;316-322
141. Sweeney K.J., Swarbrick A., Sutherland R.L., Musgrove E.A. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells. Oncogene. 16:1998;2865-2878
142. Tan P., Cady B., Wanner M., Worland P., Cukor B., Magi-Galluzzi C., et al. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1 a, b) invasive breast carcinomas. Cancer Research. 57:1997;1259-1263
143. Tetsu O., McCormick F. Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell. 3:2003;233-245
144. Tokuyama Y., Henning H.F., Kawamura K., Tarapore P., Fukasawa K. Specific phosphorylation of nucleophosmin on Thr199 by CDK2/cyclin E, and its role in centrosome duplication. Journal of Biological Chemistry. 27:2001;27
145. van den Heuvel S., Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 262:1993;2050-2054
146. Vlach J., Hennecke S., Amati B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO Journal. 16:1997;5334-5344
147. Wang C., Chua K., Seghezzi W., Lees E., Gozani O., Reed R. Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis. Genes Development. 12:1998;1409-1414
148. Vogt B., Zerfass-Thome K., Schulze A., Botz J.W., Zwerschke W., Jansen-Durr P. Regulation of cyclin E gene expression by the human papillomavirus type 16 E7 oncoprotein. Journal of General Virology. 80:1999;2103-2113
149. Wang X.D., Rosales J.L., Magliocco A., Gnanakumar R., Lee K.Y. Cyclin F in breast tumors is cleaved into its low molecular weight forms by calpain. Oncogene. 22:2003;769-774
150. Wang A., Yoshimi N., Suzui M., Yamauchi A., Tarao M., Mon H. Different expression patterns of cyclins A, D1 and E in human colorectal cancer. Journal of Cancer Research, Clinical Oncology. 122:1996;122-126
151. Weaver E.J., Kovatich A.J., Bibbo M. Cyclin E expression and early cervical neoplasia in thin prep specimens. A feasibility study. Acta Cytology. 44:2000;301-304
152. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330
153. Welcker M., Singer J., Loeb K.R., Grim J.E., Bloecher A., Gurien-West M., et al. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Molecular Cells. 12:2003;381-392
154. Winey M. Cell cycle: Driving the centrosome cycle. Current Biology. 9:1999;R449-452
155. Winston J.T., Chu C., Harper J.W. Culprits in the degradation of cyclin E apprehended. Genes Development. 13:1999;2751-2757
156. Wolowiec D., Benchaib M., Pernas P., Deviller P., Souchier C., Rimolkh R., et al. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue. Leukemia. 9:1995;1382-1388
157. Won K.A., Reed S.I. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO Journal. 15:1996;4182-4193
158. Woo M.S., Sanchez I., Dynlacht B.D. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Molecular and Cellular Biology. 17:1997;3566-3579
159. Xiao Z.X., Ginsberg D., Ewen M., Livingston D.M. Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases. Proceedings of the National Academic Sciences of the United States of America. 93:1996;4633-4637
160. Yasui W., Kuniyasu H., Yokozaki H., Semba S., Shimamoto F., Tahara E. Expression of cyclin F in colorectal adenomas and adenocarcinomas: Correlation with expression of Ki-67 antigen and p53 protein. Virchows Archives. 429:1996;13-19
161. Yasui W., Kudo Y., Semba S., Yokozaki H., Tahara E. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Japan Journal of Cancer Research. 88:1997;625-629
162. Ye X., Wei Y., Nalepa G., Harper J.W. The cyclin E/Cdk2 Substrate p220(NPAT) Is Required for S-Phase Entry, Histone Gene Expression, and Cajal Body Maintenance in Human Somatic Cells. Molecular and Cellular Biology. 23:2003;8586-8600
163. Zariwala M., Liu J., Xiong Y. Cyclin E2, a novel human G1 cyclin and activating parmer of CDK2 and CDK3, is induced by viral oncoproteins. Oncogene. 17:1998;2787-2798
164. Zhang H., Xiong Y., Beach D. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Molecular Biology of Cells. 4:1993;897-906
165. Zhang H.S., Gavin M., Dahiya A., Postigo A.A., Ma D., Luo R.X., et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell. 101:2000;79-89
166. Zhao J., Dynlacht B., Imai T., Hori T., Harlow E. Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes Development. 12:1998;456-461
167. Zhao J., Kennedy B.K., Lawrence B.D., Barbie D.A., Matera A.G., Fletcher J.A., et al. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Development. 14:2000;2283-2297
168. Zhu L., Enders G., Lees J.A., Be ersbergen R.L., Bernards R., Harlow E. The pRB-related protein p107 contains two growth suppression domains: Independent interactions with E2F and cyclin/cdk complexes. EMBO Journal. 14:1995;1904-1913
169. Zhu L., Harlow E., Dynlacht B.D. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Development. 9:1995;1740-1752
170. Zou L., StilIman B. Assembly of a complex containing Cdc45p, replication protein A, and Mcm2p at replication origins controlled by S-phase cyclin-dependent kinases and Cdc7p-Dbf4p kinase. Molecular and Cellular Biology. 20:2000;3086-3096